[go: up one dir, main page]

WO2008148573A3 - Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms - Google Patents

Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms Download PDF

Info

Publication number
WO2008148573A3
WO2008148573A3 PCT/EP2008/004567 EP2008004567W WO2008148573A3 WO 2008148573 A3 WO2008148573 A3 WO 2008148573A3 EP 2008004567 W EP2008004567 W EP 2008004567W WO 2008148573 A3 WO2008148573 A3 WO 2008148573A3
Authority
WO
WIPO (PCT)
Prior art keywords
pantothenic acid
treatment
active substance
derivatives
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/004567
Other languages
German (de)
French (fr)
Other versions
WO2008148573A2 (en
Inventor
Marianne Petersen-Braun
Sabine Rabini
Sabine Glaeser
Klaus Kluthe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Consumer Care AG
Original Assignee
Bayer Consumer Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care AG filed Critical Bayer Consumer Care AG
Priority to RU2009148577/15A priority Critical patent/RU2472499C2/en
Priority to EP08773373A priority patent/EP2164481A2/en
Priority to BRPI0812750-6A2A priority patent/BRPI0812750A2/en
Publication of WO2008148573A2 publication Critical patent/WO2008148573A2/en
Publication of WO2008148573A3 publication Critical patent/WO2008148573A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to combinations comprising at least one active substance from the group encompassing pantothenic acid and pantothenic acid derivatives, particularly dexpanthenol, and at least one anti-allergic substance for the treatment of allergy symptoms of the skin or mucous membrane, medicaments containing said combinations, and the production thereof.
PCT/EP2008/004567 2007-06-08 2008-06-07 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms Ceased WO2008148573A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2009148577/15A RU2472499C2 (en) 2007-06-08 2008-06-07 Therapeutic agent containing combination of active substances containing pantothenic acid or its derivatives for treating allergic symptoms
EP08773373A EP2164481A2 (en) 2007-06-08 2008-06-07 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms
BRPI0812750-6A2A BRPI0812750A2 (en) 2007-06-08 2008-06-07 UNDERSTANDING AN ACTIVE SUBSTANCE COMBINATION FOR TREATMENT OF ALLERGY SYMPTOMS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07011305 2007-06-08
EP07011305.5 2007-06-08

Publications (2)

Publication Number Publication Date
WO2008148573A2 WO2008148573A2 (en) 2008-12-11
WO2008148573A3 true WO2008148573A3 (en) 2009-05-07

Family

ID=39926674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/004567 Ceased WO2008148573A2 (en) 2007-06-08 2008-06-07 Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms

Country Status (4)

Country Link
EP (1) EP2164481A2 (en)
BR (1) BRPI0812750A2 (en)
RU (1) RU2472499C2 (en)
WO (1) WO2008148573A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010260808A (en) * 2009-05-01 2010-11-18 Ikeda Mohando:Kk Oral pharmaceutical composition for improving skin condition
EP2838509A4 (en) * 2012-04-16 2015-03-11 Zemtsov Entpr Llc FORMULATIONS AND METHODS FOR THE TREATMENT OF SKIN INFLAMMATORY DISEASES
RU2542448C1 (en) * 2013-10-15 2015-02-20 Открытое акционерное общество "Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко" Pharmaceutical composition in form of foam aerosol possessing anti-inflammatory, regenerative and antimicrobial action, and method for preparing it
NZ728487A (en) * 2014-08-08 2021-07-30 Shenzhen Hightide Biopharmaceutical Ltd Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
RU2605617C1 (en) * 2015-06-25 2016-12-27 государственное автономное научное учреждение "Институт стратегических исследований Республики Башкортостан " Composition for nasal preparation
ES2653787B1 (en) * 2016-07-07 2018-09-25 Diater Laboratorio De Diagnóstico Y Aplicaciones Terapéuticas, S.A. CHROMOGLITIC ACID COMPOSITIONS FOR THE TREATMENT OF DERMATITIS
RU2646494C1 (en) * 2017-07-05 2018-03-05 Общество с ограниченной ответственностью "НАТУРА СИБЕРИКА" (сокращенно ООО "НАТУРА СИБЕРИКА") Cosmetic composition against inflammation on skin for usage as part of the cosmetic products
UA122811C2 (en) 2018-08-10 2021-01-06 Наталія Миколаївна Тихонівська PHARMACEUTICAL COMPOSITION
CN111388673A (en) * 2020-03-22 2020-07-10 华中科技大学同济医学院附属协和医院 Anti-allergic external gel film and preparation method thereof
EP4566595A1 (en) * 2023-12-07 2025-06-11 Bernhard Roth Combination preparation for the treatment of acute and chronic rhinosinusitis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2841527A (en) * 1955-11-07 1958-07-01 Us Vitamin Corp Medicinal emulsions
WO2001019330A1 (en) * 1999-09-15 2001-03-22 Roche Consumer Health Ag Pharmaceutical and/or cosmetical compositions
JP2005053907A (en) * 2003-08-01 2005-03-03 Boehringer Ingelheim Internatl Gmbh Pharmaceutical composition for treating skin disease containing combination of epinastine and one or more kinds of additional anti-h1-histamines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2841527A (en) * 1955-11-07 1958-07-01 Us Vitamin Corp Medicinal emulsions
WO2001019330A1 (en) * 1999-09-15 2001-03-22 Roche Consumer Health Ag Pharmaceutical and/or cosmetical compositions
JP2005053907A (en) * 2003-08-01 2005-03-03 Boehringer Ingelheim Internatl Gmbh Pharmaceutical composition for treating skin disease containing combination of epinastine and one or more kinds of additional anti-h1-histamines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200521, Derwent World Patents Index; AN 2005-199939, XP002503480 *

Also Published As

Publication number Publication date
RU2472499C2 (en) 2013-01-20
RU2009148577A (en) 2011-07-20
EP2164481A2 (en) 2010-03-24
BRPI0812750A2 (en) 2014-12-23
WO2008148573A2 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
WO2008148573A3 (en) Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms
WO2011061330A3 (en) Use of physiological cooling active ingredients, and agents containing such active ingredients
PT2222669E (en) Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
WO2008128740A8 (en) Titration of tapentadol
MX342643B (en) Pharmaceutical dosage forms comprising poly(e-caprolactone).
IN2012DN01435A (en)
IN2012DN02805A (en)
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
WO2008058547A3 (en) Alpha-lactalbumin composition
WO2010121177A3 (en) Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2007048801A3 (en) Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2010090494A3 (en) Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
AU2013330679A8 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
EP2746254A3 (en) Oxadiazole derivative active on sphingosine-1-phosphate (s1p)
GB2446341A (en) Method and system for transdermal drug delivery
WO2008043788A3 (en) Novel compounds
AU2012308243A8 (en) Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
WO2008092219A3 (en) Pharmaceutical composition comprising tramadol and ketoprofen
JP2009001575A5 (en)
WO2008063311A3 (en) Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08773373

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008773373

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009148577

Country of ref document: RU

ENP Entry into the national phase

Ref document number: PI0812750

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20091208